Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification

Centre Hospitalier Universitaire, Amiens · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
naosteoporosisslesystemicsystemic-lupus-erythematosus
osteoporosis, lupus erythematosus, systemic, cardiovascular calcification, rank: receptor activator of nuclear factor kappa b, rankl: receptor activator of nuclear factor kappa b ligand, opg: osteoprotegerin, sle: systemic lupus erythematosus, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805684
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.